Editorial: Age-related macular degeneration: Why should stroke physicians care?

Stroke

Volumn 41, Issue 4, 2010, Pages 575-576

  Wong, Tien Y ^a,b  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Age related macular degeneration; Epidemiology; Stroke; Vascular endothelial growth factor

Indexed keywords

APOLIPOPROTEIN E; BEVACIZUMAB; RANIBIZUMAB; VASCULOTROPIN A;

BRAIN HEMORRHAGE; CAROTID ARTERY DISEASE; CHOROID CAPILLARY LAYER; CLINICAL TRIAL; DRUG MEGADOSE; DRUSEN; EDITORIAL; FIBROSIS; HUMAN; HYPERTENSION; INFLAMMATION; LOW DRUG DOSE; PIGMENT EPITHELIUM; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SCAR; SMOKING; STROKE; SUBRETINAL NEOVASCULARIZATION; TAIWAN; VISUAL IMPAIRMENT; VITREOUS BODY; DRUG ANTAGONISM; FACTUAL DATABASE; META ANALYSIS; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; RETINA MACULA DEGENERATION;

DATABASES, FACTUAL; HUMANS; MACULAR DEGENERATION; META-ANALYSIS AS TOPIC; RISK FACTORS; STROKE; TAIWAN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950216897     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.574475     Document Type: Editorial

References (15)

1. Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology. 2008;115:116-126.
2. Klein R, Peto T, Bird A, VanNewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004;137:486-495.
3. Baker ML, Hand PJ, Wang JJ, Wong TY. Retinal signs and stroke: revisiting the link between the eye and brain. Stroke. 2008;39:1371-1379.
4. Wong TY. Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies. Am J Ophthalmol. 2009;148:327-329.
5. Wong TY, Klein R, Sun C, Mitchell P, Couper DJ, Lai H, Hubbard D, Sharrett AR; Atherosclerosis Risk in Communities Study. Age-related macular degeneration and risk for stroke. Ann Intern Med. 2006;145: 98-106.
6. Liao D, Mo J, Duan Y, Klein R, Scott IU, Huang KA, Zhou H. Is age-related macular degeneration associated with stroke among elderly Americans? Open Ophthalmol J. 2008;2:37-42.
7. Tan JS, Wang JJ, Liew G, Rochtchina E, Mitchell P. Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol. 2008;92:509-512.
8. Hu CC, Ho JD, Lin HC. Neovascular age-related macular degeneration and the risk of stroke: a five year population-based follow-up study. Stroke. 2009;40:2685-2690.
9. Laude A, Cackett PD, Vithana EN, et al. Polypoidal choroidal vascu-lopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res. 2009 Oct 23 [Epub ahead of print].
10. Wong TY, Liew G, Mitchell P. Clinical update: new treatments for age-related macular degeneration. Lancet. 2007;370:204-206.
11. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431.
12. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group. Ranibizumab versus verte-porfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444.
13. Gillies MC, Wong TY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2007;356:748-749.
14. Boyer DS, Heier JS, Brown DM, Francom SF, Ianchulev T, Rubio RG. A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology. 2009; 116:1731-1739.
15. Schmidt-Erfurth U. Clinical safety of ranibizumab in age-related macular degeneration. Expert Opin Drug Saf. 2010;9:149-165.